David Wang

Director/Miembro de la Junta en BIOVAXYS TECHNOLOGY CORP. .

Fortuna: 85 077 $ al 31/05/2024

Non-Energy Minerals

Health Technology

Consumer Services

Perfil

David Wang is currently the Chief Executive Officer at Encounter Technology Ltd., Director at BioVaxys Technology Corp., and Director at BioVaxys LLC.
Previously, he worked as the Chief Executive Officer at Beijing Century Medical.
Mr. Wang holds an MBA from the University of International Business.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
BIOVAXYS TECHNOLOGY CORP 1.03%	08/02/2023	1 492 575 ( 1.03% )	85 077 $	31/05/2024

Cargos activos de David Wang

Empresas	Cargo	Inicio
BIOVAXYS TECHNOLOGY CORP.	Director/Miembro de la Junta	-
BioVaxys LLC BioVaxys LLC BiotechnologyHealth Technology BioVaxys LLC is a clinical stage biotechnology company, which engages in the development of immunotherapeutic vaccines for antiviral and individualized cancer therapy. It focuses on multihaptenized autologous vaccine that will initially be developed and marketed for melanoma and ovarian cancer. The company was founded by James Passin, Kenneth Kovan and David Berd and is headquartered in New York, NY.	Director/Miembro de la Junta	-
Encounter Technology Ltd.	Director Ejecutivo	-

Todos los cargos activos de David Wang

Antiguos cargos conocidos de David Wang.

Empresas	Cargo	Fin
Beijing Century Medical	Director Ejecutivo	-

Ver el detalle de la experiencia de David Wang.

Formación de David Wang.

University of International Business

Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de David Wang.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
BIOVAXYS TECHNOLOGY CORP.	Non-Energy Minerals

Empresas privadas	3
BioVaxys LLC BioVaxys LLC BiotechnologyHealth Technology BioVaxys LLC is a clinical stage biotechnology company, which engages in the development of immunotherapeutic vaccines for antiviral and individualized cancer therapy. It focuses on multihaptenized autologous vaccine that will initially be developed and marketed for melanoma and ovarian cancer. The company was founded by James Passin, Kenneth Kovan and David Berd and is headquartered in New York, NY.	Health Technology
Beijing Century Medical
Encounter Technology Ltd.

Ver las conexiones de la empresa